BRCA2-IN-2
BRCA2-IN-2 (Compound 3i) has a strong binding affinity to the BRCA2 protein. BRCA2-IN-2 can inhibit the proliferation of breast cancer cells and scavenge DPPH free radicals. BRCA2-IN-2 has anti-tumor and antioxidant activities[1].
Product Specifications
UNSPSC
12352211
Target
Reactive Oxygen Species (ROS)
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Smiles
NS(=O)(C1=CC=C(C=C1)/N=N/C2=CC=C(C(/C=N/C3=NC=CC=C3)=C2)O)=O
Molecular Formula
C18H15N5O3S
Molecular Weight
381.41
References & Citations
[1]Rezaeianzadeh O, et al. Synthesis and application of diazenyl sulfonamide-based schiff bases as potential BRCA2 active inhibitors against MCF-7 breast cancer cell line. Sci Rep. 2025 Feb 24;15 (1) :6661.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-168993/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6375708-01 0.1 mL
DCAKD (Dephospho-CoA Kinase Domain-containing Protein, FLJ22955) (MaxLight 750)
Ask
View Details MBS6375708-02 5x 0.1 mL
DCAKD (Dephospho-CoA Kinase Domain-containing Protein, FLJ22955) (MaxLight 750)
Ask
View Details 
abx213636-01 50 µL
Glial Cell Line Derived Neurotrophic Factor Receptor Alpha 1 (GFRA1) Antibody
Ask
View Details abx213636-02 100 µL
Glial Cell Line Derived Neurotrophic Factor Receptor Alpha 1 (GFRA1) Antibody
Ask
View Details 